HSBC Holdings’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $319K | Buy |
66,554
+9,960
| +18% | +$47.8K | ﹤0.01% | 1947 |
|
|
2025
Q1 | $259K | Buy |
56,594
+8,545
| +18% | +$39.1K | ﹤0.01% | 2020 |
|
|
2024
Q4 | $229K | Buy |
48,049
+21,584
| +82% | +$103K | ﹤0.01% | 2233 |
|
|
2024
Q3 | $124K | Buy |
+26,465
| New | +$124K | ﹤0.01% | 2374 |
|
|
2024
Q1 | – | Sell |
-29,207
| Closed | -$123K | – | 2695 |
|
|
2023
Q4 | $123K | Buy |
+29,207
| New | +$123K | ﹤0.01% | 2094 |
|
|
2023
Q1 | – | Sell |
-10,548
| Closed | -$77.6K | – | 2511 |
|
|
2022
Q4 | $77.6K | Buy |
+10,548
| New | +$77.6K | ﹤0.01% | 2447 |
|
|
2022
Q3 | – | Sell |
-12,201
| Closed | -$132K | – | 2784 |
|
|
2022
Q2 | $132K | Sell |
12,201
-1,188
| -9% | -$12.9K | ﹤0.01% | 2555 |
|
|
2022
Q1 | $153K | Buy |
+13,389
| New | +$153K | ﹤0.01% | 2664 |
|